Tympanostomy tube delivery systems
Customize your policy alerts
Sign up for select_health Policy CCP.1558 alerts
Get alerted when Policy CCP.1558 changes without checking for updates manually.
Monitor payer policy activity
Coverage and medical necessity determination for automated and non-fully automated tympanostomy tube placement systems (including Tula, Hummingbird, Solo+) for Select Health of South Carolina members.
No material clinical or coverage changes in this revision.
Coverage Determinations
Not medically necessary — automated and iontophoresis-assisted systems
Not medically necessary when device is an automated or iontophoresis-assisted tympanostomy tube delivery system
Supported by evidence limitations: primarily prospective single-arm studies, small regulatory and implementation reports, lack of randomized trials, and outcomes focused on technical success rather than comparative health outcomes (hearing, infection recurrence, quality of life, repeat tube placement, durability).
Automated tympanostomy tube placement systems are excluded from coverage as investigational/not medically necessary. This includes fully automated systems and iontophoresis-assisted delivery platforms such as the Tula® System; claims for these devices may be denied on that basis.
The available evidence has not established that fully automated or non-fully automated tympanostomy tube delivery systems provide clinical benefit compared with conventional tympanostomy tube placement. Studies are primarily prospective single‑arm series, small regulatory reports, and a heterogeneous systematic review; randomized comparative trials were not identified. Outcomes reported in the literature focus on technical success, tolerability, tube retention, and procedural adverse events rather than definitive patient‑centered outcomes such as hearing, infection recurrence, quality of life, or need for repeat tube placement. For these reasons, fully automated systems (including iontophoresis‑assisted devices) and non‑fully automated single‑pass devices are considered investigational and not medically necessary.
Related Codes
| 0583T | Tympanostomy (requiring insertion of ventilating tube), using an automated tube delivery system, iontophoresis local anesthesia |
Provider Actions and Billing
Prior authorization not supported for automated systems
Fully automated tympanostomy tube placement systems (for example, devices described by CPT 0583T) are classified as investigational/not medically necessary and are not covered; prior authorization for these investigational device procedures is not supported.
Use established OR or manual in‑office techniques first
Standard tympanostomy tube placement performed in the operating room under general anesthesia and manual in‑office placement (non‑proprietary or operator‑controlled single‑pass devices) are the established approaches; use of office‑based automated devices should be documented against accepted clinical indications if attempted, but automated device use remains investigational.
Coding and documentation for automated delivery (CPT 0583T)
When billing for tympanostomy tube services, providers commonly submit CPT code 0583T for tympanostomy using an automated tube delivery system with iontophoresis local anesthesia; documentation should reflect the device and technique used and support medical necessity per standard indications for tube insertion.
Claims for fully automated or iontophoresis‑assisted systems may be denied
Use of fully automated tympanostomy tube placement systems — including automated delivery systems, iontophoresis‑assisted systems, and the Tula System — is considered investigational/not clinically proven and therefore not medically necessary; claims for such devices may be denied on that basis.
Background
Tympanostomy tube delivery systems are intended to facilitate tube placement in office or other lower‑acuity settings to avoid operating room scheduling and general anesthesia. Fully automated systems (for example, platforms combining iontophoresis‑delivered local anesthesia with an automated myringotomy and tube delivery) and non‑fully automated single‑pass devices (handheld devices that consolidate myringotomy and tube placement while retaining operator control) have been studied primarily for technical performance and tolerability. The evidence base is limited, composed largely of single‑arm and observational studies, and does not demonstrate improved comparative health outcomes across routine practice environments; therefore these delivery systems remain investigational for routine coverage.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.